 This study found that lung cancer screening, LCS, detected several comorbidities in patients from developing countries, including cardiovascular disease, emphysema, osteoporosis, hepatic steatosis, and other conditions such as coronary artery calcifications and skeletal muscle atrophy. These findings suggest that LCS can be used to identify and treat comorbidities in developing countries. This article was authored by Julian Nascimento-Domatos, Carlos Eugenio Santiago Manuela Ziru, and others.